AAAAAA

   
Results: 1-25 | 26-33
Results: 1-25/33
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS HEMATOPOIETIC PROGENITOR-CELL SUPPORT AS PART OF COMBINED-MODALITY THERAPY INPATIENTS WITH INFLAMMATORY BREAST-CANCER
Authors: CAGNONI PJ NIETO Y SHPALL EJ BEARMAN SI BARON AE ROSS M MATTHES S DUNBAR SE JONES RB
Citation: Pj. Cagnoni et al., HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS HEMATOPOIETIC PROGENITOR-CELL SUPPORT AS PART OF COMBINED-MODALITY THERAPY INPATIENTS WITH INFLAMMATORY BREAST-CANCER, Journal of clinical oncology, 16(5), 1998, pp. 1661-1668
CORRELATION OF TUMOR O-6 METHYLGUANINE-DNA METHYLTRANSFERASE LEVELS WITH SURVIVAL OF MALIGNANT ASTROCYTOMA PATIENTS TREATED WITH BIS-CHLOROETHYLNITROSOUREA - A SOUTHWEST-ONCOLOGY-GROUP STUDY
Authors: JAECKLE KA EYRE HJ TOWNSEND JJ SCHULMAN S KNUDSON HM BELANICH M YAROSH DB BEARMAN SI GIROUX DJ SCHOLD SC
Citation: Ka. Jaeckle et al., CORRELATION OF TUMOR O-6 METHYLGUANINE-DNA METHYLTRANSFERASE LEVELS WITH SURVIVAL OF MALIGNANT ASTROCYTOMA PATIENTS TREATED WITH BIS-CHLOROETHYLNITROSOUREA - A SOUTHWEST-ONCOLOGY-GROUP STUDY, Journal of clinical oncology, 16(10), 1998, pp. 3310-3315
TREATMENT OF SEVERE VENOOCCLUSIVE DISEASE WITH DEFIBROTIDE - COMPASSIONATE USE RESULTS IN RESPONSE WITHOUT SIGNIFICANT TOXICITY IN A HIGH-RISK POPULATION
Authors: RICHARDSON PG ELIAS AD KRISHNAN A WHEELER C NATH R HOPPENSTEADT D KINCHLA NM NEUBERG D WALLER EK ANTIN JH SOIFFER R VREDENBURGH J LILL M WOOLFREY AE BEARMAN SI IACOBELLI M FAREED J GUINAN EC
Citation: Pg. Richardson et al., TREATMENT OF SEVERE VENOOCCLUSIVE DISEASE WITH DEFIBROTIDE - COMPASSIONATE USE RESULTS IN RESPONSE WITHOUT SIGNIFICANT TOXICITY IN A HIGH-RISK POPULATION, Blood, 92(3), 1998, pp. 737-744
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT FOR PRIMARY BREAST-CANCER IN PATIENTS WITH 4-9 INVOLVED AXILLARY LYMPH-NODES
Authors: BEARMAN SI OVERMOYER BA BOLWELL BJ TAYLOR CW SHPALL EJ CAGNONI PJ MECHLING BE RONK B BARON AE PURDY MH ROSS M JONES RB
Citation: Si. Bearman et al., HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT FOR PRIMARY BREAST-CANCER IN PATIENTS WITH 4-9 INVOLVED AXILLARY LYMPH-NODES, Bone marrow transplantation, 20(11), 1997, pp. 931-937
PERIPHERAL-BLOOD STEM-CELLS FOR AUTOGRAFTING
Authors: SHPALL EJ CAGNONI PJ BEARMAN SI ROSS M JONES RB
Citation: Ej. Shpall et al., PERIPHERAL-BLOOD STEM-CELLS FOR AUTOGRAFTING, Annual review of medicine, 48, 1997, pp. 241-251
TREATMENT OF SEVER VENOOCCLUSIVE DISEASE (VOD) WITH DEFIBROTIDE (DF) - COMPASSIONATE USE RESULTS IN EFFICACY WITHOUT SIGNIFICANT TOXICITY IN A HIGH-RISK POPULATION
Authors: RICHARDSON PG ELIAS AD KRISHNAN A WHEELER C NATH R HOPPENSTEADT D WALLER EK ANTIN JH SOIFFER RJ VREDENBURGH J BEARMAN SI IACOBELLI M FAREED J GUINAN EC
Citation: Pg. Richardson et al., TREATMENT OF SEVER VENOOCCLUSIVE DISEASE (VOD) WITH DEFIBROTIDE (DF) - COMPASSIONATE USE RESULTS IN EFFICACY WITHOUT SIGNIFICANT TOXICITY IN A HIGH-RISK POPULATION, Blood, 90(10), 1997, pp. 1107-1107
TREATMENT OF HEPATIC VENOCCLUSIVE DISEASE WITH RECOMBINANT HUMAN TISSUE-PLASMINOGEN ACTIVATOR AND HEPARIN IN 42 MARROW TRANSPLANT PATIENTS
Authors: BEARMAN SI LEE JL BARON AE MCDONALD GB
Citation: Si. Bearman et al., TREATMENT OF HEPATIC VENOCCLUSIVE DISEASE WITH RECOMBINANT HUMAN TISSUE-PLASMINOGEN ACTIVATOR AND HEPARIN IN 42 MARROW TRANSPLANT PATIENTS, Blood, 89(5), 1997, pp. 1501-1506
OVERVIEW OF CONDITIONING RELATED LIFE-THREATENING TOXICITIES OF MARROW TRANSPLANTATION
Authors: BEARMAN SI
Citation: Si. Bearman, OVERVIEW OF CONDITIONING RELATED LIFE-THREATENING TOXICITIES OF MARROW TRANSPLANTATION, Seminars in respiratory and critical care medicine, 17(5), 1996, pp. 365-372
BONE-MARROW METASTASES
Authors: SHPALL EJ GEE AP HOGAN C CAGNONI P GEHLING U HAMI L FRANKLIN W BEARMAN SI ROSS M JONES RB
Citation: Ej. Shpall et al., BONE-MARROW METASTASES, Hematology/oncology clinics of North America, 10(2), 1996, pp. 321
HIGH-DOSE PACLITAXEL, CYCLOPHOSPHAMIDE, AND CISPLATIN WITH AUTOLOGOUSHEMATOPOIETIC PROGENITOR-CELL SUPPORT - A PHASE-I TRIAL
Authors: STEMMER SM CAGNONI PJ SHPALL EJ BEARMAN SI MATTHES S DUFTON C DAY T TAFFS S HAMI L MARTINEZ C PURDY MH ARRON J JONES RB
Citation: Sm. Stemmer et al., HIGH-DOSE PACLITAXEL, CYCLOPHOSPHAMIDE, AND CISPLATIN WITH AUTOLOGOUSHEMATOPOIETIC PROGENITOR-CELL SUPPORT - A PHASE-I TRIAL, Journal of clinical oncology, 14(5), 1996, pp. 1463-1472
PACLITAXEL-CONTAINING HIGH-DOSE CHEMOTHERAPY - THE UNIVERSITY-OF-COLORADO EXPERIENCE
Authors: CAGNONI PJ SHPALL EJ BEARMAN SI MATTHES S ROSS M TAFFS S JONES RB
Citation: Pj. Cagnoni et al., PACLITAXEL-CONTAINING HIGH-DOSE CHEMOTHERAPY - THE UNIVERSITY-OF-COLORADO EXPERIENCE, Seminars in oncology, 23(6), 1996, pp. 43-48
USE OF AMIFOSTINE IN BONE-MARROW PURGING
Authors: CAGNONI PJ JONES RB BEARMAN SI ROSS M HAMI L FRANKLIN WA CAPIZZI R SCHEIN PS SHPALL EJ
Citation: Pj. Cagnoni et al., USE OF AMIFOSTINE IN BONE-MARROW PURGING, Seminars in oncology, 23(4), 1996, pp. 44-48
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS HEMATOPOIETIC PROGENITOR-CELL SUPPORT FOR METASTATIC AND HIGH-RISK PRIMARY BREAST-CANCER
Authors: BEARMAN SI SHPALL EJ JONES RB CAGNONI PJ ROSS M
Citation: Si. Bearman et al., HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS HEMATOPOIETIC PROGENITOR-CELL SUPPORT FOR METASTATIC AND HIGH-RISK PRIMARY BREAST-CANCER, Seminars in oncology, 23(1), 1996, pp. 60-67
CLINICAL EFFICACY OF PLATELETS COLLECTED WITH COBE SPECTRA LRS SYSTEM
Authors: AMBRUSO DR BEARMAN SI DUMONT L HIESTER A ROSS M SMITHBURGER D NEWCOMB J
Citation: Dr. Ambruso et al., CLINICAL EFFICACY OF PLATELETS COLLECTED WITH COBE SPECTRA LRS SYSTEM, Blood, 88(10), 1996, pp. 1326-1326
USE OF CD34 POSITIVE AUTOLOGOUS HEMATOPOIETIC PROGENITORS TO SUPPORT PATIENTS WITH BREAST-CANCER AFTER HIGH-DOSE CHEMOTHERAPY
Authors: CAGNONI PJ JONES RB FRANKLIN W HAMI L BERENSON RJ JACOBS C ROSS M BEARMAN SI SHPALL EJ
Citation: Pj. Cagnoni et al., USE OF CD34 POSITIVE AUTOLOGOUS HEMATOPOIETIC PROGENITORS TO SUPPORT PATIENTS WITH BREAST-CANCER AFTER HIGH-DOSE CHEMOTHERAPY, Blood, 86(10), 1995, pp. 1533-1533
THE SYNDROME OF HEPATIC VENOOCCLUSIVE DISEASE AFTER MARROW TRANSPLANTATION
Authors: BEARMAN SI
Citation: Si. Bearman, THE SYNDROME OF HEPATIC VENOOCCLUSIVE DISEASE AFTER MARROW TRANSPLANTATION, Blood, 85(11), 1995, pp. 3005-3020
HEPATIC VENOOCCLUSIVE DISEASE FOLLOWING B ONE-MARROW TRANSPLANTATION - PROCEEDINGS OF A SYMPOSIUM OF FAG AND GEGMO GROUPS
Authors: RIO B CAHN JY ATTAL M DROUET L SCROBOHACI ML DEGOS F DEGOTT C BEARMAN SI GRANENA A BLAISE D DEVERGIE A BORDIGONI P IBRAHIM A DUSURGET C GORIN NC FRANCO D HARTMAN O GLUCKMAN E
Citation: B. Rio et al., HEPATIC VENOOCCLUSIVE DISEASE FOLLOWING B ONE-MARROW TRANSPLANTATION - PROCEEDINGS OF A SYMPOSIUM OF FAG AND GEGMO GROUPS, La Presse medicale, 23(26), 1994, pp. 1217-1222
TRANSPLANTATION OF ENRICHED CD34-POSITIVE AUTOLOGOUS MARROW INTO BREAST-CANCER PATIENTS FOLLOWING HIGH-DOSE CHEMOTHERAPY - INFLUENCE OF CD34-POSITIVE PERIPHERAL-BLOOD PROGENITORS AND GROWTH-FACTORS ON ENGRAFTMENT
Authors: SHPALL EJ JONES RB BEARMAN SI FRANKLIN WA ARCHER PG CURIEL T BITTER M CLAMAN HN STEMMER SM PURDY M MYERS SE HAMI L TAFFS S HEIMFELD S HALLAGAN J BERENSON RJ
Citation: Ej. Shpall et al., TRANSPLANTATION OF ENRICHED CD34-POSITIVE AUTOLOGOUS MARROW INTO BREAST-CANCER PATIENTS FOLLOWING HIGH-DOSE CHEMOTHERAPY - INFLUENCE OF CD34-POSITIVE PERIPHERAL-BLOOD PROGENITORS AND GROWTH-FACTORS ON ENGRAFTMENT, Journal of clinical oncology, 12(1), 1994, pp. 28-36
COMPARISON OF MORBIDITY AND MORTALITY AFTER MARROW TRANSPLANTATION FROM HLA-GENOTYPICALLY IDENTICAL SIBLINGS AND HLA-PHENOTYPICALLY IDENTICAL UNRELATED DONORS
Authors: BEARMAN SI MORI M BEATTY PG MEYER WG BUCKNER CD PETERSEN FB SANDERS JE ANASETTI C MARTIN P APPELBAUM FR HANSEN JA
Citation: Si. Bearman et al., COMPARISON OF MORBIDITY AND MORTALITY AFTER MARROW TRANSPLANTATION FROM HLA-GENOTYPICALLY IDENTICAL SIBLINGS AND HLA-PHENOTYPICALLY IDENTICAL UNRELATED DONORS, Bone marrow transplantation, 13(1), 1994, pp. 31-35
FUTURE STRATEGIES FOR THE TREATMENT OF ADVANCED EPITHELIAL OVARIAN-CANCER USING HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW SUPPORT
Authors: SHPALL EJ JONES RB BEARMAN SI PURDY MP
Citation: Ej. Shpall et al., FUTURE STRATEGIES FOR THE TREATMENT OF ADVANCED EPITHELIAL OVARIAN-CANCER USING HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW SUPPORT, Gynecologic oncology, 54(3), 1994, pp. 357-361
TRANSPLANTATION OF CD34(-BLOOD PROGENITOR CELLS (PBPCS) INTO BREAST-CANCER PATIENTS FOLLOWING HIGH-DOSE CHEMOTHERAPY() MARROW AND OR PERIPHERAL)
Authors: SHPALL EJ FRANKLIN WA JONES RB BEARMAN SI PURDY MH CAGNONI P HEIMFELD S BERENSON RJ
Citation: Ej. Shpall et al., TRANSPLANTATION OF CD34(-BLOOD PROGENITOR CELLS (PBPCS) INTO BREAST-CANCER PATIENTS FOLLOWING HIGH-DOSE CHEMOTHERAPY() MARROW AND OR PERIPHERAL), Blood, 84(10), 1994, pp. 10000396-10000396
PHASE-I STUDY OF TAXOL CDDP/CYCLOPHOSPHAMIDE WITH AUTOLOGOUS HEMATOPOIETIC-CELL SUPPORT (AHCS)/
Authors: CAGNONI PJ STEMMER SM BEARMAN SI SHPALL EJ PURDY MH MYERS S JONES RB
Citation: Pj. Cagnoni et al., PHASE-I STUDY OF TAXOL CDDP/CYCLOPHOSPHAMIDE WITH AUTOLOGOUS HEMATOPOIETIC-CELL SUPPORT (AHCS)/, Blood, 84(10), 1994, pp. 10000486-10000486
DOUBLE FILTRATION OF PLATELET CONCENTRATES PRODUCES EXTENSIVE LEUKOREDUCTION WITHOUT EFFECTING RESPONSE TO PLATELET TRANSFUSION
Authors: THOMPSON HW MARTINEZ C BEARMAN SI SHPALL EJ JONES RB AMBRUSO DR
Citation: Hw. Thompson et al., DOUBLE FILTRATION OF PLATELET CONCENTRATES PRODUCES EXTENSIVE LEUKOREDUCTION WITHOUT EFFECTING RESPONSE TO PLATELET TRANSFUSION, Blood, 84(10), 1994, pp. 10000672-10000672
AMIFOSTINE (WR-2721) SHORTENS THE ENGRAFTMENT PERIOD OF 4-HYDROPEROXYCYCLOPHOSPHAMIDE-PURGED BONE-MARROW IN BREAST-CANCER PATIENTS RECEIVING HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS BONE-MARROW SUPPORT
Authors: SHPALL EJ STEMMER SM HAMI L FRANKLIN WA SHAW L BONNER HS BEARMAN SI PETERS WP BAST RC MCCULLOCH W CAPIZZI R MITCHELL E SCHEIN PS JONES RB
Citation: Ej. Shpall et al., AMIFOSTINE (WR-2721) SHORTENS THE ENGRAFTMENT PERIOD OF 4-HYDROPEROXYCYCLOPHOSPHAMIDE-PURGED BONE-MARROW IN BREAST-CANCER PATIENTS RECEIVING HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS BONE-MARROW SUPPORT, Blood, 83(11), 1994, pp. 3132-3137
POSITIVE SELECTION OF CD34+ HEMATOPOIETIC PROGENITOR CELLS FOR TRANSPLANTATION
Authors: SHPALL EJ JONES RB BEARMAN SI STEMMER SM PURDY MH HEIMFELD S BERENSON RJ
Citation: Ej. Shpall et al., POSITIVE SELECTION OF CD34+ HEMATOPOIETIC PROGENITOR CELLS FOR TRANSPLANTATION, Stem cells, 11, 1993, pp. 48-49
Risultati: 1-25 | 26-33